Latest filing published 18 Mar 2025 for biote Corp., €134k. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Filings by Bret Christensen span 2 companies, the busiest being Insulet Corp and biote Corp. In total, 13 filings cover trades dated from 18 August 2021 to 17 March 2025.
Both buying and selling appear: 1 purchase worth €134k, against 3 sales worth €2.4M. Taken together, the sales exceed the purchases by €2.2M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 8 share grants and 1 option exercise. Since January 2025: 1 purchase and no sales on the market.
The newest entry dates from 18 March 2025: an open-market purchase of €134k, in biote Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations